Canine Mobility and Degenerative Joint Disease: Welfare Management

Osteoarthritis and degenerative joint disease cause chronic pain in millions of dogs, particularly older and large-breed individuals. Multimodal pain management significantly improves quality of life.

Key Facts

Canine osteoarthritis affects an estimated 20% of dogs over one year old and over 80% of dogs over 8 years
The condition is frequently under-recognised — dogs rarely vocalise pain and may simply become less active
Lameness, reluctance to rise, behavioural changes, and muscle atrophy are key indicators of chronic pain
Multimodal management combining NSAIDs, physiotherapy, weight control, and environmental modifications is most effective
Anti-nerve growth factor (anti-NGF) monoclonal antibody therapies represent a significant recent advance in pain control

Welfare Considerations

Chronic joint pain in dogs causes a sustained reduction in quality of life that is often invisible to owners because dogs are stoic and hide pain through behavioural adaptation. Many owners mistake reduced activity and reluctance to exercise for normal ageing rather than recognising it as a pain signal. Early diagnosis and aggressive multimodal pain management — combining anti-inflammatory medication, physiotherapy, hydrotherapy, appropriate exercise, and weight management — significantly improves comfort and function. Environmental modifications such as ramps, orthopaedic beds, and non-slip flooring reduce pain from daily activities. The goal is to maintain the highest possible quality of life for as long as possible.

What You Can Do

Watch for early signs of joint pain — reduced activity, stiffness after rest, reluctance to use stairs
Maintain your dog at a healthy weight — even modest weight reduction significantly reduces joint load
Discuss multimodal pain management options with your vet, including newer anti-NGF therapies
Provide environmental modifications — ramps, non-slip mats, orthopaedic bedding — to reduce daily pain